Lumbard & Kellner, LLC
- SEC CIK
- 0001602476
- Latest filing
- Aug 6, 2026
TAK holding history
Takeda Pharmaceutical Co Ltd in every 13F filed by Lumbard & Kellner, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TAK overviewAll 13F holders of TAKFull Q2 2026 holdings
- Shares (Q1 2023)
- 0
- Sold out in Q1 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2023 | 0 | $0 | 0.0% | −125,744−100.0% | Sold out | Holders |
| Q4 2022 | 125,744 | $1.96M | 1.0% | −1,202−0.9% | Reduced | Holders |
| Q3 2022 | 126,946 | $1.65M | 0.9% | −2,651−2.0% | Reduced | Holders |
| Q2 2022 | 129,597 | $1.82M | 0.9% | −2,919−2.2% | Reduced | Holders |
| Q1 2022 | 132,516 | $1.90M | 0.7% | 00.0% | Unchanged | Holders |
| Q4 2021 | 132,516 | $1.92M | 0.7% | −4,177−3.1% | Reduced | Holders |
| Q3 2021 | 136,693 | $2.24M | 0.9% | −1,056−0.8% | Reduced | Holders |
| Q2 2021 | 137,749 | $2.32M | 0.9% | +2,199+1.6% | Added | Holders |
| Q1 2021 | 135,550 | $2.26M | 0.8% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.